Compare Cipla with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs TTK HEALTHCARE - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA TTK HEALTHCARE CIPLA/
TTK HEALTHCARE
 
P/E (TTM) x 33.4 21.3 156.8% View Chart
P/BV x 3.4 1.4 241.0% View Chart
Dividend Yield % 0.5 1.1 43.3%  

Financials

 CIPLA   TTK HEALTHCARE
EQUITY SHARE DATA
    CIPLA
Mar-19
TTK HEALTHCARE
Mar-19
CIPLA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs6781,215 55.8%   
Low Rs484610 79.3%   
Sales per share (Unadj.) Rs198.2444.4 44.6%  
Earnings per share (Unadj.) Rs18.517.2 107.4%  
Cash flow per share (Unadj.) Rs35.027.6 126.6%  
Dividends per share (Unadj.) Rs3.005.00 60.0%  
Dividend yield (eoy) %0.50.5 94.3%  
Book value per share (Unadj.) Rs186.3177.9 104.7%  
Shares outstanding (eoy) m805.7014.13 5,702.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.92.1 142.7%   
Avg P/E ratio x31.452.9 59.3%  
P/CF ratio (eoy) x16.633.0 50.3%  
Price / Book Value ratio x3.15.1 60.8%  
Dividend payout %16.229.0 55.9%   
Avg Mkt Cap Rs m468,03112,894 3,629.7%   
No. of employees `00022.62.3 979.4%   
Total wages/salary Rs m28,5651,307 2,185.6%   
Avg. sales/employee Rs Th7,053.12,715.7 259.7%   
Avg. wages/employee Rs Th1,261.5565.3 223.2%   
Avg. net profit/employee Rs Th659.1105.4 625.3%   
INCOME DATA
Net Sales Rs m159,7106,279 2,543.6%  
Other income Rs m4,76678 6,149.3%   
Total revenues Rs m164,4756,356 2,587.6%   
Gross profit Rs m30,973496 6,249.6%  
Depreciation Rs m13,263147 9,041.0%   
Interest Rs m1,68434 4,983.1%   
Profit before tax Rs m20,791393 5,295.8%   
Minority Interest Rs m-1720-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,695149 3,824.9%   
Profit after tax Rs m14,924244 6,124.1%  
Gross profit margin %19.47.9 245.7%  
Effective tax rate %27.437.9 72.2%   
Net profit margin %9.33.9 240.8%  
BALANCE SHEET DATA
Current assets Rs m124,2662,717 4,573.3%   
Current liabilities Rs m37,7151,571 2,401.0%   
Net working cap to sales %54.218.3 296.8%  
Current ratio x3.31.7 190.5%  
Inventory Days Days9132 281.8%  
Debtors Days Days9547 203.3%  
Net fixed assets Rs m105,190991 10,614.6%   
Share capital Rs m1,611141 1,140.4%   
"Free" reserves Rs m148,5112,373 6,258.4%   
Net worth Rs m150,1232,514 5,970.8%   
Long term debt Rs m38,3013 1,126,491.2%   
Total assets Rs m239,6334,158 5,763.0%  
Interest coverage x13.312.6 105.8%   
Debt to equity ratio x0.30 18,866.8%  
Sales to assets ratio x0.71.5 44.1%   
Return on assets %6.96.7 103.9%  
Return on equity %9.99.7 102.6%  
Return on capital %11.816.9 69.9%  
Exports to sales %34.73.6 967.5%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs m55,419225 24,608.7%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m57,410225 25,492.7%   
Fx outflow Rs m19,04171 26,777.2%   
Net fx Rs m38,368154 24,899.9%   
CASH FLOW
From Operations Rs m16,911173 9,769.7%  
From Investments Rs m-16,68797 -17,292.0%  
From Financial Activity Rs m-3,487-307 1,134.8%  
Net Cashflow Rs m-3,451-38 9,154.1%  

Share Holding

Indian Promoters % 16.0 65.4 24.5%  
Foreign collaborators % 20.8 0.0 -  
Indian inst/Mut Fund % 12.2 3.7 329.7%  
FIIs % 23.7 5.2 455.8%  
ADR/GDR % 1.1 0.0 -  
Free float % 26.2 25.8 101.6%  
Shareholders   161,166 12,723 1,266.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Power and Energy Stocks Drag(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.9% while the Hang Seng is down 0.3%. The Nikkei 225 is trading down by 0.6%.

Related Views on News

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (3QFY20); Net Profit Up 9.4% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, CIPLA has posted a net profit of Rs 4 bn (up 9.4% YoY). Sales on the other hand came in at Rs 44 bn (up 9.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

CIPLA Announces Quarterly Results (2QFY20); Net Profit Up 31.2% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, CIPLA has posted a net profit of Rs 5 bn (up 31.2% YoY). Sales on the other hand came in at Rs 44 bn (up 9.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Jul 7, 2020 10:17 AM

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS